{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Return to msk.org
Memorial Sloan Kettering Cancer Center
  • Sign In
  • Live Courses
  • On Demand eLearning
  • Coming Soon
  • Visiting Us
  • About
  • Resources & Policies
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Select a button below to sign in or create an account. If you have previously registered or attended a MSK CME event, please sign in using the username and password created at course registration. MSK employees must use their SSO credentials to sign in. 

Single Sign On (MSK Employees)
Sign in or Create an Account
Enter your email and password to login:

*
*
Login

New to Memorial Sloan Kettering Cancer Center? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • ACHPN
  • ACNP
  • ACNP-BC
  • AGACNP
  • AGACNP-BC
  • AGCNS
  • AGNP
  • AGNP-BC
  • ANP
  • ANP-BC
  • AS
  • AT
  • AuD
  • BA
  • BAO
  • BCC
  • BCh
  • Bchir
  • BM
  • BS
  • BS, MS
  • BSN
  • BSN, MS
  • BSN, MS, DNP
  • CCC-SLP
  • CCLS
  • CCRN
  • CCRP
  • CEN
  • ChB
  • CIPS
  • CNM
  • CNP
  • CPNP
  • CPNP-AC
  • CRNA
  • CRNP
  • CTTS
  • D(ABMM)
  • DAc
  • DACM
  • DAHM
  • DAOM
  • DDS
  • DDS, MPH
  • DMD
  • DMD, PhD
  • DNB
  • DNP
  • DNP, RN
  • DNSc
  • DO
  • DPM
  • DPM
  • DPT
  • DrPH
  • DSc
  • DVM
  • EdD
  • EdS
  • FAAP
  • FACNM
  • FACOG
  • FACS
  • FASCRS
  • FASN
  • FCCM
  • FCCP
  • FIPP
  • FNP
  • FNP-BC
  • GNP
  • GNP-BC
  • HUC
  • JD
  • LAc
  • LCSW
  • LISW
  • LISW-S
  • LMSW
  • LPCC
  • LPN
  • LSW
  • MA
  • MAc
  • MAcOM
  • MB
  • MB, PhD
  • MBA
  • MBBCh
  • MBBCh BAO
  • MBBCh BAO, PhD
  • MBBCh, MPH
  • MBBCh, PhD
  • MBBS
  • MBBS, MPH
  • MBBS, PhD
  • MBChB
  • MD
  • MD, DSc
  • MD, FCCP
  • MD, FCCP, DAABIP
  • MD, JD
  • MD, MA
  • MD, MAS
  • MD, MBA
  • MD, MHA
  • MD, MPH
  • MD, MPH, MHS
  • MD, MS
  • MD, MS, PhD
  • MD, PhD
  • MD, PhD, MA
  • MD, PhD, MPH
  • MD, PhD, MS
  • MDiv
  • MDS
  • MEd
  • MHS
  • MPA
  • MPH
  • MPhil
  • MS
  • MSc
  • MSc, PhD
  • MSN
  • MSPH
  • NCTTP
  • None
  • NP
  • NP, RN
  • OCN
  • OD
  • Other
  • OTR
  • PA
  • PA-C
  • PCA
  • PharmD
  • PharmD, PhD
  • PhD
  • PhD, MBA, MS
  • PhD, MPH
  • PhD, MPhil
  • PhD, MS
  • PhD, MSc
  • PhD, NP, RN
  • PsyD
  • PT
  • RA
  • RCS
  • RD
  • RDCS
  • RDMS
  • RN
  • RN-BC
  • RPh
  • RRT
  • RT
  • ScD
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

3rd Annual MSK Symposium on Lymphoma


3rd Annual MSK Symposium on Lymphoma Banner

  • Overview
  • Register
  • Brochure
  • Faculty
  • Schedule
  • Support
Add to Calendar 3rd Annual MSK Symposium on Lymphoma 5/11/2018 7:30:00 AM 5/12/2018 4:00:00 PM America/New_York For More Details: https://mskcc.cloud-cme.com/course/courseoverview?EID=2631 Description: This symposium will feature updated information on lymphoma biology, diagnosis, immunology, and genetics, and ongoing efforts to translate the scientific discoveries into novel treatment strategies for a variety of lymphomas. Faculty will review the current standard of care and present their own perspectives on how they treat various types of lymphomas. Participants will have the opportunity to discuss ... Zuckerman Research Center 417 E 68th St false MM/DD/YYYY


Date & Location
Friday, May 11, 2018, 7:30 AM - Saturday, May 12, 2018, 4:00 PM, Zuckerman Research Center 417 E 68th St

Specialties
Specialties - Bone Marrow Transplant, Hematology, Medical Oncology, Oncology and Hematology, Pathology, Physician Assistant, Radiation Oncology

Overview

This symposium will feature updated information on lymphoma biology, diagnosis, immunology, and genetics, and ongoing efforts to translate the scientific discoveries into novel treatment strategies for a variety of lymphomas. Faculty will review the current standard of care and present their own perspectives on how they treat various types of lymphomas. Participants will have the opportunity to discuss diagnostic and management cases, and how to incorporate biologic and genetic biomarkers into clinical practice and clinical trials.

Target Audience

The target audience includes medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in diagnosis, treatment, and biomedical research of lymphoma.

Symposium Highlights

Networking Cocktail Reception - Participants are invited to join course director, Dr. Anas Younes, and the entire course faculty for a cocktail reception on Friday evening from 5:30-6:30 pm at Zuckerman Research Center. 

Luncheon Panels - This symposium will feature two luncheon panels, one hosted by the Adult BMT Service (Friday, 1:30-2:15 pm), and the other by the Myeloma Service (Saturday, 12:15-1:00 pm). Space is limited for both luncheon events and RSVP is required during course registration.

    Adult BMT Luncheon: Are CARs Over Taking Transplant in Lymphoma?
    Faculty: Miguel-Angel Perales, MD and Craig S. Sauter, MD
    View the Adult BMT Luncheon Program

    Myeloma Luncheon: Genetic Characterization of Myeloma Cells and Reprogramming of T-cells: Modern Myeloma Treatment
    Faculty: C. Ola Landgren, MD, PhD, Sham Mailankody, MBBS and Malin Hultcrantz, MD PhD
    View the Myeloma Luncheon Program

Special Discount Offer - Attendees registered for the 3rd Annual MSK Symposium on Lymphoma (May 11-12) will receive a registration discount to attend the Masterclass in Lymphoma Pathology (May 12-13). Please see details below.


Objectives
  1. To provide up-to-date information on recent molecular diagnostic methods
  2. To provide up-to-date information on recent update on lymphoma pathology classification
  3. To provide up-to-date information on recent treatment options for patients with Hodgkin and non-Hodgkin lymphoma

Registration

Registration Fees   
Physicians (MDs, PhDs and DOs)  $400 
Nurses, PAs and Other Healthcare Professionals        $200 
Residents and Fellows  $150 
Industry Professionals*  $700 

*Industry professionals may attend CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities.

*Special Discount Offer - Attendees registered for the 3rd Annual MSK Symposium on Lymphoma (May 11-12) will receive a registration discount to attend the Masterclass in Lymphoma Pathology (May 12-13). Once you register for the 3rd Annual MSK Symposium on Lymphoma, you will receive an email confirmation with a promotion code to use for the Masterclass in Lymphoma Pathology. If you have any questions, please email [email protected]. 

Registration Details

Registration includes continental breakfast, lunch, and refreshment breaks. Please contact [email protected] at least one week prior to the course if you have any special dietary needs.

  • 30% Discounted Rate for MSK Alumni and MSK Alliance Members - MSK offers a discounted rate to all MSK Alumni and MSK Alliance members to attend a CME course. Please contact [email protected] for more information or to register.
  • MSK Staff Registration - Registration is complimentary for MSK staff. However, you must complete course registration to attend this course. 

Cancellation Policy

If you cancel your participation in this course, your registration fee, less a $75 administrative fee, will be refunded when email notification is received by the MSK Office of Continuing Medical Education (MSK CME) at least 7 days prior to the first day of the course ([email protected]).

Cancellations or no-shows after this date are not eligible for a refund. MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, we will refund the registration fee in full, but are not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies. At any time, you may substitute another registrant in your place after contacting MSK CME with the relevant information.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 16.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.



Keywords:



 

MSK Symposium Chair

Anas Younes, MD
Chief, Lymphoma Service


MSK Organizing Committee

Ahmet Dogan, MD, PhD
Hans Guido Wendel, MD
Joachim Yahalom, MD, FACR
Andrew Zelenetz, MD, PhD

 

MSK Course Faculty

Maria E. Arcila, MD
Connie Lee Batlevi, MD, PhD
Renier J. Brentjens, MD, PhD
Christian Grommes, MD
Paul A. Hamlin, MD
Steven M. Horwitz, MD
Malin Hultcrantz, MD PhD
Erel Joffe, MD 
Anita Kumar, MD
C. Ola Landgren, MD, PhD
Sham Mailankody, MBBS
Alison J. Moskowitz, MD
Ariela Noy, MD
M. Lia Palomba, MD
Miguel-Angel Perales, MD
Craig S. Sauter, MD
David J. Straus, MD


Invited Course Faculty

Ash A. Alizadeh, MD, PhD
Stanford University
Stanford, CA 

Marc André, MD
Université Catholique de Louvain
Belgium 

Stephen M Ansell, MD, PhD
Mayo Clinic
Rochester, Minnesota 

Andreas Engert, MD
University Hospital of Cologne
Germany 

Jude Fitzgibbon, PhD
Barts Cancer Institute
England 

John P. Leonard, MD
Weill Cornell Medical College
New York, NY 

Ronald Levy, MD
Stanford University
Stanford, CA 

David Maloney, MD, PhD
Fred Hutchinson Cancer Research Center
Seattle, WA 

Ari M. Melnick, MD
Weill Cornell Medical College
New York, NY 

Franck Morschhauser, MD
Centre Hospitalier Régional Universitaire de Lille
France 

Sattva S. Neelapu, MD
MD Anderson Cancer Center 
Houston, Texas 

Laura Pasqualucci, MD
Columbia University
New York, NY 

Davide Rossi, MD, PhD
The Institute of Oncology Research
Switzerland 

Stephen J. Schuster, MD
The University of Pennsylvania
Philadelphia, PA 

John Seymour, MBBS, FRACP, PhD
Peter MacCallum Cancer Centre
Australia 

Louis M. Staudt, MD, PhD
National Cancer Institute
Bethesda, MD 

Catherine Thieblemont, MD
Saint-Louis Hospital
France 

Irving Weissman, MD
Stanford University
Stanford, CA 

Wyndham Wilson, MD, PhD
National Cancer Institute
Bethesda, MD 

Thomas E. Witzig, MD
Mayo Clinic
Rochester, Minnesota 

Weili Zhao, MD, PhD
Shanghai Institute of Hematology
China

 

Faculty Disclosures (All Faculty)



Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Ash Alizadeh, MD, PhD
Stanford Medicine
Faculty
Marc Andre, MD
CHU UCL Namur, Université Catholique de Louvain
Belgium
Faculty
Nothing to disclose
Stephen M Ansell, MD, PhD
Mayo Clinic
Faculty
Nothing to disclose
Maria E. Arcila, MD
MSK
Faculty
Nothing to disclose
Connie Lee Batlevi, MD, PhD
MSK
Faculty
Nothing to disclose
Renier Brentjens, MD, PhD
Roswell Park Comprehensive Cancer Center
Faculty
co-founder, stockholder and consultant -JUNO Therapeutics
Ahmet Dogan, MD, PhD
MSK
Faculty
Consulting Fee-Peer Review Institute|Consulting Fee-Roche|Consulting Fee-Novartis AG|Consulting Fee-Seattle Genetics
Andreas Engert, MD
University Hospital of Cologne
Faculty
Consulting Fee-Takeda Pharmaceuticals, Inc.|Contracted Research-Takeda Pharmaceuticals, Inc.|Consulting Fee-Bristol-Myers Squibb|Contracted Research-Bristol-Myers Squibb
Jude Fitzgibbon, PhD
Barts Cancer Institute, Queen Mary University of London
United Kingdom
Faculty
Speakers Bureau-Gilead|consultancy fee and research funding -Epizyme
Christian Grommes, MD
MSK
Faculty
Advisory Board-BTG pharmaceutical
Paul A Hamlin, MD
MSK
Faculty
Consulting Fee-celgene|Consulting Fee-Genentech, Inc.|Consulting Fee-Gilead|Contracted Research-Portola Pharmaceuticals, Inc.|Contracted Research-molecular templates|Contracted Research-Seattle Genetics|Contracted Research-Novartis AG
Steven Horwitz, MD
MSK
Faculty
Consulting Fee-Takeda Pharmaceuticals, Inc.|Consulting Fee-Kiowa|Consulting Fee-seattle genetics|Contracted Research-celgene|Contracted Research-Takeda Pharmaceuticals, Inc.|Contracted Research-kiowa|Contracted Research-seattle genetics|Contracted Research-ADCT Therapeutics|Contracted Research-trillium|Contracted Research-verastem|Contracted Research-aileron
Erel Joffe, MD
MSK
Faculty
Nothing to disclose
Anita Kumar, MD
MSK
Faculty
Research Support-Seattle Genetics, Pharmacyclics, Adaptive Biotechnologies, Celegene and Genentech/AbbVie|Honorarium-Celegene
John Leonard, MD
Weill Cornell Medical College
Faculty
Consulting Fee-Celgene|Consulting Fee-Juno|Consulting Fee-BMS|Consulting Fee-Sutro|Consulting Fee-Genentech/Roche|Consulting Fee-Pfizer|Consulting Fee-Biotest|Consulting Fee-United Therapeutics|Consulting Fee-Karyopharm|Consulting Fee-ADC Therapeutics|Consulting Fee-MEI Pharma|Consulting Fee-AstraZeneca|Consulting Fee-Novartis
Ronald Levy, MD
Stanford Medicine
Faculty
Consulting Fee-Five Prime|Consulting Fee-Kite Pharma|Consulting Fee-BeiGene|Consulting Fee-Innate Pharma|Consulting Fee-Immune Design|Consulting Fee-Corvus|Contracted Research-Bristol-Myers Squibb|Contracted Research-Pfizer, Inc.|Contracted Research-Pharmacyclics, Inc.|Contracted Research-Dynavax
David G. Maloney, MD, PhD
Fred Hutchinson Cancer Research Center
Faculty
Research funding to my institution-Juno Therapeutics|Consulting Fee-Kite Pharma, Inc.|Consulting Fee-Celgene
Ari Melnick, MD
Weill Cornell Medicine
Faculty
Consulting Fee-Celgene
Franck Morschhauser, MD
Universite of Lille, CHU Lille
Faculty
Alison Moskowitz, MD
MSK
Faculty
Consulting Fee-Seattle Genetics|Consulting Fee-Bristol-Myers Squibb
Sattva S Neelapu, MD
The University of Texas MD Anderson Cancer Center
Faculty
Consulting Fee-Kite Pharma|Consulting Fee-Merck and Company, Inc.|Consulting Fee-Novartis AG|Consulting Fee-Celgene
Ariela Noy, MD
MSK
Faculty
Speakers Bureau-Pharmacyclics, Inc.|Consulting Fee-janssen|Speakers Bureau-prime oncology|Speakers Bureau-prime oncology|Consulting Fee-medscape
Lia Palomba, MD
MSK
Faculty
Nothing to disclose
Laura Pasqualucci, MD
Columbia University VagelosCollege of Physician & Surgeons
Faculty
Nothing to disclose
Davide Rossi, MD
Institute of Southern Switzerland IOSI
Switzerland
Faculty
Consulting Fee-Johnson and Johnson|Consulting Fee-Roche|Consulting Fee-Gilead
Stephen J Schuster, MD
The University of Pennsylvania
Faculty
Consulting Fee-Celgene |Consulting Fee-Dava Oncology |Contracted Research-Celgene|Consulting Fee-Genentech, Inc.|Consulting Fee-Gilead|Consulting Fee-Merck and Company, Inc.|Contracted Research-Merck and Company, Inc.|Consulting Fee-Novartis AG|Contracted Research-Novartis AG|Consulting Fee-Pharmacyclics, Inc.|Contracted Research-Pharmacyclics, Inc.|Consulting Fee-Janssen|Contracted Research-Janssen|Consulting Fee-Seattle Genetics
John F Seymour, MBBS, FRACP, PhD
Peter MacCallum Cancer Centre
Australia
Faculty
Consulting Fee-AbbVie|Consulting Fee-Acerta|Consulting Fee-Celgene|Consulting Fee-Janssen|Consulting Fee-Roche
Louis M Staudt, MD, PhD, Center Director, NCI
National Cancer Institute
Faculty
Nothing to disclose
David J Straus, MD
MSK
Faculty
Nothing to disclose
Catherine Thieblemont, MD
Saint-Louis Hospital
France
Faculty
Nothing to disclose
Irving Weissman, MD
Standord University
Faculty
Consulting Fee-No Commercial entity
Hans-Guido Wendel, MD
MSK
Faculty
Wyndham Wilson, MD, PhD
National Cancer Institute
Australia
Faculty
Nothing to disclose
Thomas E Witzig, MD
Mayo Clinic
Faculty
Nothing to disclose
Joachim Yahalom, MD
MSK
Faculty
Nothing to disclose
Anas Younes, MD
MSK
Faculty
Consulting Fee-Bayer Corporation|Consulting Fee-Merck and Company, Inc.|Consulting Fee-Genentech, Inc.|Research Support-Novartis AG|Research Support-Bristol-Myers Squibb
Andrew D Zelenetz, MD, PhD
MSK
Faculty
Consulting-Genentech/Roche, GSK, Celgene, Gilead, Janssen, Amgen, Takeda, MEI Pharma|Research-Roche, Gilead, MEI Pharma, BeiGene
Weili Zhao, MD
Shanghai Rui Jin Hospital
China
Faculty
Nothing to disclose

Friday, May 11, 2018
 
Friday

Disclosure
8:00AM - 8:01AM
Disrupting the CD47-SIRPa Anti-phagocytic Axis to Treat Cancer
8:00AM - 9:00AM
Irving Weissman, MD
State of the Lymphoma at Memorial Sloan Kettering
9:00AM - 9:45AM
Anas Younes, MD
Diffuse Large B Cell Lymphoma (DLBCL)
9:45AM - 10:00AM
Andrew D Zelenetz, MD, PhD
T Cell Lymphoma
10:00AM - 10:15AM
Steven Horwitz, MD
Mantle Cell Lymphoma
10:15AM - 10:30AM
John Leonard, MD
MCL Trials at MSKCC
10:30AM - 10:45AM
Anita Kumar, MD
HIV Lymphoma
10:45AM - 11:00AM
Ariela Noy, MD
Panel Discussion
11:00AM - 11:30AM
John Leonard, MD
Follicular Lymphoma (FL)
11:45AM - 12:00PM
John F Seymour, MBBS, FRACP, PhD
Hodgkin Lymphoma (HL)
12:00PM - 12:15PM
Andreas Engert, MD
HL Trials at MSKCC
12:15PM - 12:30PM
Alison Moskowitz, MD
Marginal Zone Lymphoma
12:30PM - 12:45PM
Catherine Thieblemont, MD
Double Hit Lymphoma
12:45PM - 1:00PM
Wyndham Wilson, MD, PhD
Panel Discussion
1:00PM - 1:30PM
Marc Andre, MD
Identifying New Therapeutic Targets in Follicular Lymphoma
2:30PM - 2:45PM
Hans-Guido Wendel, MD
Mechanism-based Therapy of DLBCL
2:45PM - 3:00PM
Louis M Staudt, MD, PhD, Center Director, NCI
Epigenetic Evolution in Lymphoma
3:00PM - 3:15PM
Ari Melnick, MD
Genetic Landscape of Follicular Lymphoma
3:15PM - 3:30PM
Jude Fitzgibbon, PhD
Genetic Cooperation in Lymphomagenesis
3:30PM - 3:45PM
Laura Pasqualucci, MD
Panel Discussion- Session II Faculty
3:45PM - 4:00PM
Marc Andre, MD
Case Presentations
4:15PM - 4:30PM
Joachim Yahalom, MD
When Do I Use Combined Modality Therapy in DLBCL
4:30PM - 4:45PM
Paul A Hamlin, MD
When Do I Use Combined Modality Therapy in Early Stage HL
4:45PM - 5:00PM
Marc Andre, MD
Comining Immune Therapy with Radiation Therapy for Relapsed HL
5:00PM - 5:15PM
Lia Palomba, MD
Panel Discussion
5:15PM - 5:30PM
Andreas Engert, MD
John F Seymour, MBBS, FRACP, PhD
Thomas E Witzig, MD
Saturday, May 12, 2018
 
Saturday

Disclosure
8:00AM - 8:01AM
Introduction to Clinical Diagnostic Genome Sequencing
8:00AM - 8:30AM
Maria E. Arcila, MD
Moderator
8:05AM - 8:15AM
Ahmet Dogan, MD, PhD
Genome Sequencing and Outcome of Therapy in DLBCL
8:30AM - 8:45AM
Weili Zhao, MD
Genome Sequencing of DLBCL Using Clinical Assays at Memorial Sloan Kettering
8:45AM - 9:00AM
Erel Joffe, MD
Clinical Application of ctDNA in NHL
9:00AM - 9:15AM
Ash Alizadeh, MD, PhD
Assessment of ctDNA in HL
9:15AM - 9:30AM
Davide Rossi, MD
Panel Discussion- Session V Faculty
9:30AM - 9:45AM
Genomic Classification of DLBCL, Implications for Precision Medicine
10:00AM - 10:30AM
Louis M Staudt, MD, PhD, Center Director, NCI
Biomarker Selection: Targeting EZH2
10:30AM - 10:45AM
Franck Morschhauser, MD
Biomarker Selection: Combined HDAC and BCL2 Inhibitors
10:45AM - 11:00AM
Connie Lee Batlevi, MD, PhD
Biomarker-driven Trials in Lymphoma: Histologyspecific or Across Lymphoma Histologies
11:00AM - 11:15AM
Thomas E Witzig, MD
Immune Therapy in the Era of Precision Medicine
11:15AM - 11:30AM
Ronald Levy, MD
Introduction to Lymphoma Master Protocol “MasterLymph”
11:30AM - 11:45AM
Anas Younes, MD
Panel Discussion- Session VI Faculty
11:45AM - 12:00PM
Moderator
1:10PM - 1:11PM
Lia Palomba, MD
CAR T-cell: Transcend Study
1:15PM - 1:30PM
David G. Maloney, MD, PhD
CAR T-cell: ZUMA-1 Study
1:30PM - 1:45PM
Sattva S Neelapu, MD
CAR T-cell: Juliet Study
1:45PM - 2:00PM
Stephen J Schuster, MD
New Approaches
2:00PM - 2:15PM
Renier Brentjens, MD, PhD
Immune Checkpoint Inhibitors
2:15PM - 2:30PM
Stephen M Ansell, MD, PhD
Panel Discussion- Session VII Faculty
2:30PM - 3:00PM
Moderator
3:14PM - 3:15PM
Paul A Hamlin, MD
How I Treat CNS Lymphoma at the NCI
3:15PM - 3:30PM
Wyndham Wilson, MD, PhD
How I Treat CNS Lymphoma at Memorial Sloan Kettering
3:30PM - 3:45PM
Christian Grommes, MD
Panel Discussion- Session VIII Faculty
3:45PM - 4:00PM

Memorial Sloan Kettering gratefully acknowledges the following organizations for providing educational grants and financial support for this live activity:

  • AbbVie
  • Bayer HealthCare Pharmaceuticals, Inc.
  • Celgene Corporation
  • Genentech
  • Gilead Sciences
  • Janssen Research & Development, LLC
  • Kite, A Gilead Company
  • Novartis
  • Seattle Genetics, Inc.


CME Courses

Live Courses
On Demand eLearning
Coming Soon

Resources & Policies

CME Program Terms of Use
Registration Discounts
Cancellation Policy
Industry Professionals

Attendee & Faculty Information

My CME / Attendee Resources
Claim RSS Credit (MSK Staff)
Faculty Disclosure Form
Faculty Tasks Page

Connect

Locations & Visitor Info
Help / Contact Us
Subscribe to CME Announcements




MSK CME

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

©2025 Memorial Sloan Kettering Cancer Center